Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival
Anna van der Voort, Marte C Liefaard, Mette S van Ramshorst, Erik van Werkhoven, Joyce Sanders, Jelle Wesseling, Astrid Scholten, Marie Jeanne T F D Vrancken Peeters, Linda de Munck, Sabine Siesling, Gabe S Sonke
Research output: Contribution to journal › Article › Academic › peer-review
10Citations
(Scopus)
66Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival'. Together they form a unique fingerprint.